The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


ZANIDIP



Clear PharmacyPPA1596/009/002

Main Information

Trade NameZANIDIP
Active SubstancesLERCANIDIPINE HYDROCHLORIDE
Dosage FormFilm Coated Tablet
Licence HolderClear Pharmacy
Licence NumberPPA1596/009/002

Group Information

ATC CodeC08CA13 lercanidipine

Status

License statusWithdrawn
Withdrawn Date29/01/2018
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
« Back